Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries:: role of the EP3 receptor

被引:30
|
作者
van Rodijnen, William F.
Korstjens, Iolente J.
Legerstee, Natalee
ter Wee, Piet M.
Tangelder, Geert-Jan
机构
[1] Free Univ Amsterdam, Cardiovasc Res Inst, Physiol Lab, Med Ctr, NL-1081 BT Amsterdam, Netherlands
[2] Free Univ Amsterdam, Dept Nephrol, Cardiovasc Res Inst, Med Ctr, NL-1081 BT Amsterdam, Netherlands
关键词
interlobular arteries; vasoconstriction;
D O I
10.1152/ajprenal.00351.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Evidence indicates that prostaglandin E-2 ( PGE(2)) preferentially affects preglomerular renal vessels. However, whether this is limited to small-caliber arterioles or whether larger vessels farther upstream also respond to PGE(2) is currently unclear. In the present study, we first investigated the effects of PGE(2) along the preglomerular vascular tree and subsequently focused on proximal interlobular arteries ( ILAs). Proximal ILAs in hydronephrotic rat kidneys as well as isolated vessels from normal kidneys constricted in response to PGE(2), both under basal conditions and after the induction of vascular tone. By contrast, smaller vessels, i. e., distal ILAs and afferent arterioles, exhibited PGE(2)-induced vasodilation. Endothelium removal and pretreatment of single, isolated proximal ILAs with an EP1 receptor blocker ( SC51322, 1 mu mol/ l) or a thromboxane A(2) receptor blocker ( SQ29548, 1 mu mol/ l) did not prevent vasoconstriction to PGE(2). Furthermore, in the presence of SC51322, responses of these vessels to PGE(2) and the EP1/EP3 agonist sulprostone were superimposable, indicating that PGE(2)-induced vasoconstriction is mediated by EP3 receptors on smooth muscle cells. Immunohistochemical staining of proximal ILAs confirmed the presence of EP3 receptor protein on these cells and the endothelium. Adding PGE(2) to normal isolated kidneys induced a biphasic flow response, i. e., an initial flow increase at PGE(2) concentrations <= 0.1 mu mol/ l followed by a flow decrease at 1 mu mol/ l PGE(2). Thus our results demonstrate that PGE(2) affects multiple segments of the preglomerular vascular tree in a different way. At the level of the proximal ILAs, PGE(2) had a direct vasoconstrictor action mediated by EP3 receptors.
引用
收藏
页码:F1094 / F1101
页数:8
相关论文
共 50 条
  • [21] Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation
    Natura, Gabriel
    Baer, Karl-Juergen
    Eitner, Annett
    Boettger, Michael K.
    Richter, Frank
    Hensellek, Susanne
    Ebersberger, Andrea
    Leuchtweis, Johannes
    Maruyama, Takayuki
    Hofmann, Gunther Olaf
    Halbhuber, Karl-Juergen
    Schaible, Hans-Georg
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (33) : 13648 - 13653
  • [22] Enhancement of allergic asthma in mice lacking the prostaglandin E2 receptor EP3 subtype
    Yamane, H
    Matsuoka, T
    Segi, E
    Kunikata, T
    Tanaka, H
    Nagai, H
    Kobayashi, T
    Sugimoto, Y
    Ichikawa, A
    Narumiya, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 130P - 130P
  • [23] Characterization of prostaglandin E2 EP3 receptor isoforms in mouse spinal motor neuron
    Kosuge, Yasuhiro
    Shinomiya, Takashi
    Ishige, Kumiko
    Kawaguchi, Mitsuru
    Ito, Yoshihisa
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S157 - S157
  • [24] Prostaglandin E2 and EP3 Activation Potentiate Human Platelet Responsiveness
    Rocca, Bianca
    Petrucci, Giovanna
    Patrono, Carlo
    CIRCULATION, 2009, 120 (18) : S1148 - S1148
  • [25] Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development
    Sung, YM
    He, GB
    Fischer, SM
    CANCER RESEARCH, 2005, 65 (20) : 9304 - 9311
  • [26] Inhibition of the Prostaglandin E2 EP3 Receptor Does Not Affect Beta Adrenergic Signaling in the Heart
    Bryson, Timothy D.
    Pandrangi, Teja S.
    Khan, Safa Z.
    Xu, Jiang
    Peterson, Edward
    Harding, Pamela
    FASEB JOURNAL, 2018, 32 (01):
  • [27] Prostaglandin E2 and EP3 activation potentiate human platelet responsiveness
    Rocca, B.
    Petrucci, G.
    Rutella, S.
    Pocaterra, D.
    De Cristofaro, R.
    Patrono, C.
    EUROPEAN HEART JOURNAL, 2010, 31 : 974 - 974
  • [28] Antagonists of the EP3 Receptor for Prostaglandin E2 Are Novel Antiplatelet Agents That Do Not Prolong Bleeding
    Singh, Jasbir
    Zeller, Wayne
    Zhou, Nian
    Hategen, Georgeta
    Mishra, Rama
    Polozov, Alex
    Yu, Peng
    Onua, Emmanuel
    Zhang, Jun
    Zembower, David
    Kiselyov, Alex
    Ramirez, Jose L.
    Sigthorsson, Gudmundur
    Bjornsson, Jon Mar
    Thorsteinsdottir, Margret
    Andresson, Thorkell
    Bjarnadottir, Maria
    Magnusson, Olafur
    Fabre, Jean-Etienne
    Stefansson, Kari
    Gurney, Mark E.
    ACS CHEMICAL BIOLOGY, 2009, 4 (02) : 115 - 126
  • [29] Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury
    Han, Xiaoning
    Lan, Xi
    Li, Qiang
    Gao, Yufeng
    Zhu, Wei
    Cheng, Tian
    Maruyama, Takayuki
    Wang, Jian
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (06): : 1059 - 1074
  • [30] Knockout Or Antagonism Of The Prostaglandin E2 Ep3 Receptor Is Protective In A Mouse Model Of Myocardial Infarction
    Bryson, Timothy D.
    Maxwell, DruAnne
    Taube, David
    Xu, Jiang
    Peterson, Edward
    Harding, Pamela
    HYPERTENSION, 2022, 79